TP53 mutations in lower-grade glioma have previously been associated with the disease, along with IDH1, FUBP1, ATRX, CIC, NOTCH1, EGFR, and PIK3CA29 among which we see some interactions. Here, IDH1 is linked to central nervous system cancer.